Nivolumab in Treating Patients With High-Risk Kidney Cancer Before Surgery

Clinical trial NCT02595918 · TERMINATED

Trial details

NCT number: NCT02595918
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Clear Cell Renal Cell Carcinoma Metastatic Renal Cell Carcinoma Stage I Renal Cell Cancer AJCC v6 and v7 Stage II Renal Cell Cancer AJCC v7 Stage III Renal Cell Cancer AJCC v7 Stage IV Renal Cell Cancer AJCC v7

Start date: 2016-05-19
Primary completion: 2020-08-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.